| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | Chief Executive Officer | Jan 24, 2024 | Sale | $21.64 | 7,635 | 165,221 | 49,436 | Jan 24, 2024, 04:20 PM | |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | Chief Executive Officer | Jan 09, 2024 | Sale | $22.99 | 12,066 | 277,397 | 40,053 | Jan 09, 2024, 04:28 PM | |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | Chief Executive Officer | Aug 08, 2023 | Sale | $25.48 | 10,178 | 259,335 | 26,592 | Aug 10, 2023, 04:07 PM | |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | Chief Executive Officer | Jun 30, 2023 | Sale | $28.36 | 11,449 | 324,694 | 14,079 | Jun 30, 2023, 04:05 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Jun 08, 2021 | Option Exercise | $177.00 | 1,086 | 192,222 | 90,688 | Jun 09, 2021, 04:52 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Dec 16, 2020 | Option Exercise | $157.96 | 21,395 | 3,379,554 | 70,562 | Dec 18, 2020, 05:09 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Jun 08, 2020 | Option Exercise | $114.61 | 1,642 | 188,190 | 48,019 | Jun 09, 2020, 04:58 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Mar 02, 2020 | Option Exercise | $90.54 | 1,401 | 126,847 | 49,661 | Mar 03, 2020, 06:18 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Feb 07, 2020 | Option Exercise | $102.97 | 1,594 | 164,134 | 40,182 | Feb 10, 2020, 04:58 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Jun 07, 2019 | Option Exercise | $118.61 | 1,643 | 194,876 | 41,776 | Jun 11, 2019, 06:38 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Feb 28, 2019 | Option Exercise | $132.93 | 670 | 89,063 | 33,991 | Mar 04, 2019, 05:36 PM | |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Goff Brian | EVP & Chief Commercial Officer | Feb 07, 2019 | Option Exercise | $119.57 | 1,596 | 190,834 | 34,661 | Feb 11, 2019, 06:20 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | Goff Brian | EVP & Chief Commercial Officer | Jun 08, 2018 | Sale | $118.53 | 1,645 | 194,982 | 36,257 | Jun 12, 2018, 04:51 PM | |
| ALXN | ALEXION PHARMACEUTICALS INC | Goff Brian | EVP & Chief Commercial Officer | Feb 08, 2018 | Sale | $116.31 | 1,651 | 192,028 | 28,962 | Feb 08, 2018, 07:17 PM | |
| BXLT | Baxalta Inc | Goff Brian | EVP and President, Hematology | Mar 07, 2016 | Option Exercise | $39.74 | 267 | 10,611 | 67,030 | Mar 08, 2016, 04:56 PM | |
| BXLT | Baxalta Inc | Goff Brian | EVP and President, Hematology | Mar 03, 2016 | Option Exercise | $39.30 | 1,338 | 52,583 | 67,600 | Mar 07, 2016, 06:14 PM | |
| BXLT | Baxalta Inc | Goff Brian | EVP and President, Hematology | Mar 04, 2016 | Option Exercise | $39.47 | 303 | 11,959 | 67,297 | Mar 07, 2016, 06:14 PM | |
| BXLT | Baxalta Inc | Goff Brian | EVP and President, Hematology | Feb 15, 2016 | Option Exercise | $39.00 | 533 | 20,787 | 32,827 | Feb 17, 2016, 09:10 PM |
Menu